PMID: 6103391May 17, 1980Paper

Haemostatic function and cardiovascular death: early results of a prospective study

Lancet
T W MeadeM Brozovié

Abstract

Components of the haemostatic system which may be involved in the pathogenesis of ischaemic heart disease (IHD) were measured in the Northwick Park Heart Study. Of 1510 white men aged 40-64 at recruitment, 49 have since died. 27 died from cardiovascular disease (IHD in all but 3), 18 from cancer, and 4 from other causes. The mean recruitment levels of factor VIIc, factor VIIIc, and fibrinogen were significantly higher in those who died of cardiovascular disease than in those who survived. The independent associations of factor VIIc and fibrinogen with cardiovascular death were at least as strong as the association of blood cholesterol with cardiovascular death. A clustering of two or three high clotting-factor values (factor VIIc, factor VIIIc, and fibrinogen) was present at recruitment in 63% of those who died of cardiovascular disease, compared with 23% of those who survived. The clotting-factor results appeared to be specific for cardiovascular disease: there was no evidence that high levels of factor VIIc, factor VIIIc, and fibrinogen were associated with death from cancer. The general epidemiology of factor VIIc, factor VIIIc, and fibrinogen is consistent with their having a role in the pathogenesis of IHD.

Citations

Dec 1, 1992·Clinical Cardiology·F E KuhnC E Rackley
Jul 1, 1991·European Journal of Epidemiology·A HofmanF A van den Ouweland
Jan 1, 1996·Journal of Inherited Metabolic Disease·K H SchulpisS Aronis
Jan 1, 1987·Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie·R SeitzR Egbring
Jan 1, 1992·International Journal of Clinical & Laboratory Research·G MarianiR Pasquali-Lasagni
Jan 1, 1993·International Journal of Clinical & Laboratory Research·R AbbateG F Gensini
Jan 1, 1993·International Journal of Clinical & Laboratory Research·S H DondersJ W van Wersch
Jan 1, 1993·International Journal of Clinical & Laboratory Research·J W van Wersch
Jan 1, 1997·International Journal of Clinical & Laboratory Research·K K Wu
Jan 1, 1988·La Ricerca in Clinica E in Laboratorio·M Cattaneo, P M Mannucci
Dec 1, 1993·Aging : Clinical and Experimental Research·P F LaharragueJ X Corberand
Aug 21, 2009·Histochemistry and Cell Biology·W Scott ArgravesChristian C Haudenschild
Jan 28, 1991·Biochimica Et Biophysica Acta·W M UedelhovenP C Weber
May 6, 1982·Clinica Chimica Acta; International Journal of Clinical Chemistry·D J RichardsonT J Peters
Apr 30, 1990·Clinica Chimica Acta; International Journal of Clinical Chemistry·M C AlessiI Juhan-Vague
Sep 14, 1991·Clinica Chimica Acta; International Journal of Clinical Chemistry·J W Van WerschW J Venekamp
Jan 1, 1992·Molecular Aspects of Medicine·C Rice-Evans, K R Bruckdorfer
May 19, 1993·Journal of Chromatography·J P McConnell, D J Anderson
Oct 1, 1989·Journal of the American College of Cardiology·C J HoffmanM B Hultin
Jan 1, 1989·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·K Van AckerI De Leeuw
Dec 23, 1998·Atherosclerosis·R S Rosenson, G D Lowe
Feb 20, 2003·Thrombosis Research·Markus LinsRüdiger Simon
Apr 9, 1983·Lancet·H C SimpsonL Woolf
Nov 10, 1984·Lancet·K G Green

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.